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Abstract
Sleep disturbances have been shown to be associated with 
diabetes control, but the relation between planned wakings or 
napping with glycemic indices has not been evaluated yet. This 
study evaluated the relation between sleep quality, duration, and 
pattern, including daytime napping of people with diabetes and 
their glycemic control. A cross-sectional correlation research 
design was used for this study. We enrolled 118 people with 
type 2 diabetes receiving oral agents without major complications 
at the Shahid Bahonar Center, Kerman. The age, weight, height, 
serum HbA1c, as well as other glycemic indices and lipid profile 
were measured. BMI was also calculated. All participants were 
requested to fill in the Pittsburgh Sleep Quality Index (PSQI) 
questionnaire to evaluate their sleep quality. In addition, they 
were inquired about their sleep schedule during day and night. 
Pearson correlation and multiple regression analyses were 
conducted to examine the correlation between HbA1c and sleep 
pattern variables. The variables were also compared between 
participants with or without napping using t-test. All analyses 
were performed with the SPSS version 19 (SPSS, Chicago, IL, 
USA). The mean age was 58±11 years and mean HbA1c (%) was 
7.8±11 (62±13 mmol/mol). Sleep duration and the number of 
sleep segments significantly predicted HbA1c (F (2,114)=5.232, 
P=0.007, R2=0.084). A one-hour increment in sleep duration 
was associated with a 0.174% (1.4 mmol/mol) decrement in 
HbA1c. PSQI score did not contribute to the regression model. 
Moreover, participants who napped (66%) had a lower HbA1c 
(7.6±1) compared to others (8.1±1.3) (P=0.04). We concluded 
that napping and segmented sleep are associated with a better 
glycemic control in type 2 diabetes and there is a linear 
correlation between sleep duration and better glycemic control.
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Introduction
After industrialization, lifestyle has changed considerably as well 
as sleep habits.1 People who used to get into bed a few hours 
after sunset, nowadays remain awake enjoying the advantage 
of the artificial light. Sleep deprivation is now a public health 
epidemic. In addition, the napping habit is currently not accepted 
in many cultures. Do these changes in the natural sleep pattern2 
Brief Report
What’s Known
• Napping and segmented sleep are 
associated with better glycemic control 
in type 2 diabetes.
• There is a linear correlation 
between sleep duration and better 
glycemic control.
• Sleep quality is not related to 
HbA1C.
• There is no association between 
sleep variables and lipid profi le or 
microalbuminuria.
What’s New
• Glycemic control is better in 
patients who take a nap.
• Sleep segmentation is linearly 
correlated with better glycemic control.
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could predispose to or protect us from medical 
conditions such as diabetes mellitus?
Type 2 diabetes mellitus or previously named 
non-insulin dependent diabetes mellitus is a 
condition in which the body is not able to maintain 
normal glycemic hemostasis. Many investigators 
have tried to establish the association between 
sleep, including its duration and quality, and 
diabetes risk of diabetes development or state 
of glycemic control in diabetic patients. Glycemic 
control includes short-term control, which is 
evaluated by assessing blood glucose level, and 
long-term control, which is estimated by checking 
glycosylated hemoglobin (HbA1c). HbA1c was 
first described as an unusual hemoglobin in 
diabetics by Rahbar et al.3 Subsequently, this 
protein was presented as a marker of diabetes 
control during previous weeks or months.4 Sleep 
deprivation has been shown to decrease the 
insulin sensitivity and impair glucose tolerance.5-7 
Very short sleep duration has also been 
suggested to increase the odds of diabetes in 
longitudinal studies.8-12 Likewise, sleep duration 
is suggested to be related to glycemic control 
in people with diabetes.13,14 In addition, sleep 
disturbances have been related to diabetes. In 
a longitudinal study involving 6,599 non-diabetic 
men aged 44±4 years with 14 years follow-up, 
Nilsson et al. reported that difficulties in falling 
asleep and the use of hypnotic drugs are 
associated with an increased risk of developing 
diabetes mellitus (odds ratio [OR] 1.52 [95% CI 
1.05-2.20]).15
Based on some previous studies, napping 
has been suggested to increase diabetes risk 
up to 1.4 compared with those who do not 
nap.10,16 Xue et al. in a prospective cohort study 
on 10,143 normal participants reported that 
daytime napping is associated with a higher 
risk of developing diabetes in up to nine years 
follow-up.3,10 Similar results were obtained from 
a cross-sectional study by Lam et al. in China.4
However, the aforementioned studies have 
only evaluated the odds of diabetes in the 
normal population, but the effect of napping on 
glycemic control in people with diabetes has 
not been evaluated. If we find an answer to this 
question, it may help physicians to guide their 
diabetic patients with their glycemic control.
To the best of our knowledge, the association 
between sleep pattern and diabetes has not 
been studied yet. Furthermore, in our country, 
many people have a regular daytime napping 
habit and planned wakings during nighttime, 
especially for night prayers. Previous studies 
have shown a relationship between sleep 
deprivation and glycemic control, and thus, 
we speculated that such wakings might affect 
glycemic control. This study was prospectively 
performed in a relatively homogenous group of 
people with diabetes. Sleep data were collected 
meticulously. We used the validated translation 
of the standard Pittsburgh Sleep Quality Index 
(PSQI) questionnaire to evaluate sleep quality.17 
The PSQI is a self-rated questionnaire that 
evaluates sleep quality and disturbances over 
the previous month. This questionnaire includes 
nineteen items, from which seven components 
are calculated; including sleep duration, 
sleep latency, habitual sleep efficiency, sleep 
disturbances, subjective sleep quality, use of 
sleeping medication, and daytime dysfunction. 
Global score is the sum of these seven 
components. The higher the global score, the 
worse sleep quality is reported.
This study was designed to evaluate the 
association between sleep qualities, durations, 
as well as sleep patterns, including daytime 
napping and wakings during nighttime of the 
people with diabetes and their glycemic control 
and lipid profile.
Patients and Methods
Study Population
A cross-sectional correlation research design 
was used for this study. We enrolled 118 people 
with type 2 diabetes older than 25 years 
without major complications affecting sleep, 
including ischemic heart disease, renal function 
impairment, and diabetic neuropathy. Participants 
were selected among patients who were under 
routine outpatient follow-up for diabetes control 
in Shahid Bahonar diabetes clinic. All patients 
at this center are under close follow-up and any 
alteration in the laboratory data or symptoms that 
suggest possible diabetes complication are well 
managed. Therefore, patients with any record of 
diabetes complication were excluded from this 
study. All participants were receiving only oral 
glycemic agents. The study was conducted at 
the diabetes clinic of Shahid Bahonar center in 
Kerman in 2014. Furthermore, participants with 
a history of severe obesity, obstructive sleep 
apnea, psychiatric problems, drug addiction, or 
other medical conditions affecting sleep were 
also excluded.
Variables and Methods
Anthropometric characteristics of the 
participants including height, weight, and 
age were recorded and BMI was calculated 
based on “weight (kg)/height2 (m)”. In addition, 
laboratory data, including serum HbA1c (%, 
mmol/mol), fasting blood sugar (FBS) (mg/
dl), two-hours postprandial blood sugar (BS) 
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(mg/dl), random urine micro-albumin (mg/L), 
and lipid profiles were measured for each 
individual. Patients with abnormal results 
of creatinine were excluded. We used the 
validated translation of the standard Pittsburgh 
Sleep Quality Index (PSQI) questionnaire to 
evaluate sleep quality.17
This questionnaire includes nineteen 
items, from which seven components are 
calculated; including sleep duration, sleep 
latency, habitual sleep efficiency, sleep 
disturbances, subjective sleep quality, use of 
sleeping medication, and daytime dysfunction. 
Each component is calculated based on the 
responses to some related questions and 
finally, the sum of scores for these seven 
components yields a global score. People with 
scores equal or less than five are categorized 
as good sleepers and those with scores higher 
than five are categorized as poor sleepers. 
The validity and reliability of the questionnaire 
were 86 and 89, respectively, as reported in 
a locally published manuscript (Shahrifar et 
al. 2009).17 In addition, the participants were 
inquired about the time they regularly go 
to bed, the time they get to sleep, time and 
number of wakings during night, and the 
napping time and duration.
Statistical Analysis
Spearman correlation test was used to 
measure the correlation between HbA1c and 
other continuous variables such as age, body 
mass index (BMI), waist diameter, global PSQI 
score, sleep segments, and sleep duration. 
In addition, the status of mean HbA1c was 
compared between groups with different 
sleep segments with ANOVA test. Further, 
mean HbA1c was compared between those 
who napped and those who did not nap using 
student t-test. Similar statistical method was 
performed to compare mean HbA1c between 
good sleepers (global PSQI equal or less than 5) 
and poor sleepers (global PSQI higher than 5). 
Multiple regression analysis was conducted to 
examine the relationship between HbA1c and 
various potential predictors. The variables were 
also compared between participants with or 
without napping. All analyses were performed 
with the SPSS version 19 (SPSS, Chicago, IL, 
USA). P values less than 0.05 were considered 
significant.
Ethics Statement
This study was approved by the institutional 
review board of the Kerman University of 
Medical Sciences (KMU). All participants signed 
informed consent before enrollment.
 Results
A total of 118 participants (90 males and 
28 females) with mean±SD age of 58±11 years 
were enrolled (table 1). Serum creatinine was 
higher in men (P=0.001) and BMI as well as total 
cholesterol were higher in women (P=0.03). 
Mean HbA1c (%) was 7.8±1.1 (62±13 mmol/mol).
Sleep Duration
On average, participants slept 6.6±1.5 hours 
at night and 1.3±0.6 during daytime. A negative 
correlation was observed between nighttime 
sleep duration and HbA1c (r=-0.15, P=0.09, 
NS). This linear correlation was significant when 
daytime nap duration was added to nighttime 
sleep (r=-0.2, P=0.02) (figure 1).
Table 1: Demographic and laboratory data of participants, 
comparing male versus female
Male Female P value
Age 58±11 58±12 0.53
BMI 29±4 31±5 0.03*
Waist (cm) 92±11 97±15 0.11
FBS (mmol/l) 9.3±3.6 9.4±3.4 0.83
BS 2h PP (mmol/dl) 13.3±4.3 13.4±4 0.96
HbA1c (mmol/mol) 62±15 62±12 0.80
HbA1c (%) 7.8±1.4 7.8±1.1 0.80
Serum Cr (μmol/l) 89±13 78±12 0.001
Random urine 
micro-albumin (mg/l)
27.5±29.3 356±46.4 0.18
Serum 
triglyceride (mg/dl)
2.1±0.9 1.95±0.8 0.32
Total 
cholesterol (mg/dl)
4.2±0.9 4.7±1.1 0.03
LDL cholesterol
(mg/dl)
2.5±0.9 2.7±0.9 0.29
HDL 
cholesterol (mg/dl)
1.2±0.3 1.2±0.5 0.49
*Data are presented as mean±SD
Figure 1: Scatter plot showing negative correlation between 
total hours of sleep in 24 hours and HbA1c of the patients 
with type 2 diabetes.
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Sleep Patterns
As a scale variable, the number of sleep 
segments, including nighttime and daytime 
sleeps showed a linear negative correlation 
with HbA1c (r=-0.23, P=0.01). It means that 
patients who split their sleep in more than one 
segment during 24 hours have better diabetes 
control.
As a categorical variable, considering 
the sleep pattern of the participants during 
nighttime, 57% slept once at night, 27% in 
two segments, 13% in three segments, and 
3% in four segments. Sixty-six percent of the 
participants reported that they usually take a 
daytime nap. HbA1c was compared between the 
aforementioned groups; mean HbA1c (%) was 
8±1.3 in individuals who slept once per night, 
7.6±1 in two segments group, 7.8±1.2 in three 
segments group, and 6.6±1.5 in four segments 
group. In each group, HbA1c was lower in those 
who took naps (figure 2).
Finally, participants who napped had lower 
HbA1c (7.6±1) compared to others (8.1±1.3) 
(t (115)=2.05, P=0.04). When we compared 
those who have a biphasic nighttime sleep 
with no daytime nap (two segments of sleep), 
with those who took a daytime nap in addition 
to an uninterrupted nighttime sleep (two 
segments of sleep in global), no difference 
was observed regarding HbA1c level (both 
7.9±1.1).
Sleep Quality (PSQI)
The mean global PSQI score was 
7.5±3 scores. Twenty-six percent of participants 
were good sleepers (global PSQI equal or 
less than 5). Mean HbA1c was 7.7±1.2 in 
good sleepers and 7.9±1.2 in poor sleepers 
(P=0.51, NS). As a scale variable, neither global 
PSQI score nor its component scores were 
correlated to HbA1c. Global PSQI showed a 
linear correlation with age (r=0.23, P=0.01) and 
waist diameter (r=0.19, P=0.04). The global PSQI 
score was not correlated with BMI, years with 
diabetes, glycemic indices, serum creatinine, 
urine micro-albumin, or lipid profiles. A negative 
linear correlation was observed between PSQI 
score and sleep duration (r=-0.24, P=0.007). In 
other words, sleep quality was better in longer 
sleep durations and fewer segments.
Multiple Regression Analysis
The correlation of various sleep variables 
with HbA1c level is summarized in table 2. 
A multiple regression was run to predict 
HbA1c from the total 24 h sleep duration, and 
the number of 24 h sleep segments. These 
variables significantly predicted HbA1c, 
(F(2,114)=5.232, P=0.007, R2=0.084). PSQI 
score did not contribute to the regression 
model. A one-hour increment in sleep duration 
was associated with a 0.174% (1.4 mmol/mol) 
decrement in HbA1c. Furthermore, adding one 
segment to the sleep pattern was associated 
with a 0.257% (2.8 mmol/mol) decrement in 
HbA1c. The predicted equation is presented 
as:
HbA1c (%) predicted=-0.257×sleep 
segments-0.174×total sleep duration+9.391.
Finally, we ran multiple regression test to 
check if there are any probable confounding 
factors affecting the relation of these sleep 
variables with HbA1c level. Variables including 
age, duration of diabetes, gender, waist 
diameter, BMI and total cholesterol were entered 
into the regression model from which only BMI 
and waist diameter significantly altered the effect 
size of the previously entered sleep variables 
(F(4,112)=3.833, P=0.006, R2=0.124). The new 
prediction equation is:
HbA1c (%) predicted=-0.294×sleep 
segments-0.150×total sleep duration-
0.016×waist diameter+0.047×BMI+9.511.
Figure 2: Mean HbA1c in participants with type 2 diabetes 
with different number of nighttime sleep segments. In each 
category, mean HbA1c is lower in those who take a daytime 
nap in addition to their nighttime sleep segments.
Table 2: Correlation of different sleep variables with 
HbA1c level of patients with type 2 diabetes mellitus
Variable Pearson r P value
Total 24 h sleep duration* −0.2 0.02***
Nighttime sleep duration −0.15 0.09
Total number of 24 h 
sleep segments**
−0.23 0.01*
Sleep quality
(global PSQI score)
0.05 0.58
*Including daytime nap added to nighttime sleep duration; 
**Including daytime nap and nighttime sleep segments; 
***Significant
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Association between Sleep Variables and other 
Metabolic Variables
There was no association between sleep 
duration and quality as well as sleep segments 
or napping with lipid profile status of the patients, 
including triglyceride level, total cholesterol, LDL 
cholesterol, and HDL cholesterol. Likewise, 
random urine micro albumin was not affected by 
the sleep status of patients.
Discussion
We observed that HbA1c level had a negative 
linear correlation with the number of sleep 
segments and sleep duration. In other words, 
patients who split their sleep in more than one 
segment during 24 hours have a lower HbA1c. 
Likewise, the longer the patients sleep in 
24 hours, the better their diabetes is controlled. 
Although some previous studies have shown 
that sleep duration is related to the risk of 
diabetes8,11,18,19 or worse glycemic control in 
people with diabetes,13,14 to the best of our 
knowledge, the relation between glycemic control 
and sleep segments has not been reported thus 
far. Our findings reveal that participants who split 
their sleep have a better glycemic control than 
those who have a monophasic uninterrupted 
night sleep. This effect on glycemic control 
was independent of sleep duration or quality. 
Our study indicates that participants with the 
monophasic sleep pattern show worse glycemic 
control compared to those who have split 
pattern of sleep. Although our study did not 
include normal individuals, these results may 
corroborate the theory that segmented sleep is 
more natural.2
In contrast with some previous studies, 
which have suggested that daytime napping is 
associated with increased risk of diabetes,10,16 
we demonstrated that napping is associated with 
a better glycemic control. This correlation has 
not been studied in people with diabetes before. 
Xue et al. followed a cohort of 10,143 normal 
participants and reported that daytime napping 
is associated with a higher risk of developing 
diabetes in a follow-up period of around nine 
years.3 Similar results were obtained from a 
cross-sectional study by Lam et al. in China.4 
They analyzed data from 19,567 Chinese 
men and women aged 50 years or older. The 
data originated from the Guangzhou Biobank 
Cohort Study, which was a community-based 
association study in Guangzhou, China. Data of 
napping habit was obtained by a self-reported 
questionnaire and type 2 diabetes was assessed 
by fasting blood glucose and/or self-reports of 
physician diagnosis or treatment. Participants 
reporting frequent naps were more likely to 
have diabetes. After adjustments were made 
for demographics, health status, lifestyle and 
sleep habits, adiposity, and metabolic markers, 
these relationships remained unchanged. They 
stated a similar association between napping 
and impaired fasting glucose. The authors 
concluded that napping is associated with 
elevated prevalence of diabetes and impaired 
fasting glucose. However, this association could 
not be translated as a cause-effect relationship. 
Nevertheless, the aforementioned studies have 
only evaluated the odds of diabetes in the 
normal population, but the effect of napping on 
glycemic control in people with diabetes had 
not been evaluated in previous studies. We 
detected a better glycemic control in people with 
diabetes who napped during daytime. It seems 
that napping works on glucose metabolism by 
increasing sleep segments. In fact, glycemic 
control was not different in participants who 
have two nighttime sleep segments without nap 
compared with those who have an episode of 
uninterrupted nighttime sleep plus daytime 
napping. Both aforementioned groups had two 
sleep segments in total and presented a similar 
HbA1c level. Since our study population was 
limited, additional detailed comparisons were 
impossible in order to separate the role of 
napping itself from its contribution as a sleep 
segment.
With respect to sleep duration, we found 
that total sleep duration was linearly correlated 
with better glycemic control. Borel et al. found a 
similar correlation in people with type 1 diabetes 
mellitus.20 These findings support the results of 
the Byberg et al. study, which showed a negative 
linear correlation between sleep duration and 
HbA1c.14  A total of 771 participants were selected 
from a Danish population-based cross-sectional 
‘Health 2008’ study. They measured sleep 
duration and sleep quality as well as markers of 
glucose homeostasis, including fasting plasma 
glucose, 2-h postprandial plasma glucose, 
HbA1c, two measures of insulin sensitivity (the 
insulin sensitivity index (0,120) and homeostasis 
model assessment of insulin sensitivity), the 
homeostasis model assessment of beta-cell 
function and glucose tolerance status. Multiple 
linear and logistic regression was performed 
to evaluate the associations of sleep duration 
and sleep quality with markers of glucose 
homeostasis and tolerance. Finally, they showed 
that a one-hour increment in sleep duration 
was associated with a 0.3% (3 mmol/mol) 
decrement in HbA1c. This proportion was 0.17% 
(1.4 mmol/mol) in our study. However, it should 
be stated that small R square in our predicting 
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model shows that these predictors could not 
strongly predict the HbA1c level. Byberg’s study 
was a well-designed research that evaluated 
glucose metabolism in relation to sleep duration 
and quality; however, on the one hand, the study 
population included normal healthy population 
and the conclusion may not be extrapolated 
to diabetics. On the other hand, they did not 
mention sleep pattern, which is shown to be 
associated with glycemic control in our study. 
Two recent studies on people with diabetes in 
Japan and Korea have suggested a U shaped 
correlation between sleep duration and insulin 
resistance or glycemic control.13,21 To reiterate, 
there is a strong consensus that short sleep 
is associated with worse glycemic control but 
considering long sleep, there is controversy 
among different studies.
Regarding sleep quality, our findings are in 
concordance with other studies suggesting that 
there is no correlation between sleep quality 
and glycemic control in people with diabetes.22,23 
Byberg et al. found poor sleep quality to be 
associated with earlier alterations in glucose 
homeostasis, including insulin sensitivity and 
beta-cell function, but not with later alterations 
in glucose homeostasis, i.e. HbA1c, which was 
related only with sleep duration.14 We observed 
that the sleep quality was decreased when sleep 
segments were increased. This decrease in 
the PSQI score may be due to the fact that 87 
percent of our participants were waking up during 
the night. In fact, PSQI questionnaire could not 
separate planned wakings from insomnia.
Finally, considering other metabolic markers, 
including serum lipid profile or random urine 
albumin concentration; we did not find any 
correlation between those markers with sleep 
duration, pattern, or quality of our patients. In 
a recently published manuscript, Ohkuma and 
coworkers detected that sleep duration has a U 
shape correlation with urine albumin to creatinine 
ratio.24
The main limitation of our study was the 
limited number of participants. Furthermore, 
this study was a cross-sectional correlation 
study and our findings could not be translated 
as cause and effect relationship, as diabetes 
itself independent of the obesity can cause sleep 
disruption.25 An interventional study could be 
designed to evaluate the effect of any alteration 
in sleep pattern on glycemic control more 
precisely.
Conclusion
This study indicates that, (i) napping and 
segmented sleep are associated with better 
glycemic control in type 2 diabetes, (ii) there 
is a linear correlation between sleep duration 
and better glycemic control, (iii) sleep quality is 
not related with HbA1c, and (iv) there was no 
association between sleep variables and lipid 
profile or micro albuminuria.
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